This study was conducted to examine the effect of prolonged Covid-19 symptoms on quality of life. The current study involved 153 patients who applied to the COVID-19 follow-up clinic of a public hospital in Istanbul between March 1 and May 11, 2020, and were hospitalized with a positive diagnosis of SARS-CoV-2. These patients were followed up by telephone or face-to-face in the COVID-19 follow-up outpatient clinic four to twelve weeks after recovery and discharge. According to gender, the patients were 43.3% female, 56.7% male, and the mean age was 48.130±13,388 (Min=23; Max=75), the average number of hospital stays was 7.856±4.614 (Min=1; Max=32), white cell count, which is one of the inflammatory markers, decreased significantly at the 12th week according to the measurements of the 4th week and 8th week (p<0.05). In prolonged COVID-19, myalgia was the most frequently reported symptom in 64.9%, fatigue in 62.8%, and forgetfulness in 58.7%. Other common symptoms included anxiety (58.8%), sleep disturbance (58.7%), fear (42.3%), and irritability (51.5%), and there was a significant difference as the duration increased (p =0.000) was associated with. When the results of the studies are evaluated, it is seen that the multisystemic and symptom burdens seen in patients with prolonged COVID-19 continue to affect the quality of life. It is further suggested that evidence-based studies be conducted to examine the causes of prolonged COVID-19 effects.
1. Greenhalgh T, Knight M, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.
2. Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021;82(3):378-83.
3. Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626-31.
4. Rubin R. As their numbers grow, COVID-19 “long haulers” stump experts. Jama. 2020;324(14):1381-3.
5. Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. Jama. 2020;324(6):603-5.
6. Sumantri AF, Bashari MH, Tadjoedin H, Atik N. Risk of coronavirus disease 2019 (COVID-19) infection on leukemia patients: basic science to clinical aspect. J Adv Pharm Educ Res. 2022;12(1):38-45.
7. Banda JM, Singh GV, Alser OH, Prieto-Alhambra D. Long-term patient-reported symptoms of COVID-19: an analysis of social media data. medRxiv. 2020:2020-07.
8. Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it?. Lung. 2021;199(2):113-9.
9. Yavuz MY. Ongoing Symptoms, Formation of Interstitial Lung Disease and Follow-up Process in PostCOVID-19. J Izmir Chest Hosp. 2021;35(2):53-65.
10. Kocyigit H. Reliability and validity of the Turkish version of short form-36 (SF-36): a study in a group of patients will rheumatic diseases. Turk J Drugs Ther. 1999;12:102-6.
11. Curci C, Pisano F, Bonacci E, Camozzi DM, Ceravolo C, Bergonzi R, et al. Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 Rehabilitation Unit and proposal of a treatment protocol. Eur J Phys Rehabil Med. 2020:633-41.
12. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-15.
13. Cirulli ET, Schiabor Barrett KM, Riffle S, Bolze A, Neveux I, Dabe S, Grzymski JJ, Lu JT, Washington NL. Long-term COVID-19 symptoms in a large unselected population. medrxiv. 2020:2020-10.
14. Dixit NM, Churchill A, Nsair A, Hsu JJ. Post-acute COVID-19 syndrome and the cardiovascular system: what is known?. Am Heart J Plus: Cardiol Res Pract. 2021;5:100025.
15. Vaes AW, Goërtz YM, Van Herck M, Machado FV, Meys R, Delbressine JM, et al. Recovery from COVID-19: a sprint or marathon? 6-month follow-up data from online long COVID-19 support group members. ERJ Open Res. 2021;7(2).
16. Arévalos V, Ortega-Paz L, Fernandez-Rodríguez D, Alfonso Jiménez-Díaz V, Rius JB, Campo G, et al. Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol. PLoS One. 2021;16(7):e0255263.
17. Goërtz YM, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FV, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542–02020.
18. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144.
19. Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38.
20. Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. ‘Long-COVID’: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396-8.
Copyright © 2024 - All Rights Reserved - Archives of Pharmacy Practice
Developed by Archives of Pharmacy Practice
